{
    "2019-05-08": [
        [
            {
                "time": "2018-05-30",
                "original_text": "TV pitches for prescription drugs will have to include price",
                "features": {
                    "keywords": [
                        "prescription drugs",
                        "price",
                        "TV ads"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-30",
                "original_text": "Drugmakers will have to reveal medication prices in TV ads",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "medication prices",
                        "TV ads"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-30",
                "original_text": "APNewsBreak: Drugmakers will have to reveal prices in TV ads",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "prices",
                        "TV ads"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-15",
                "original_text": "AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience",
                "features": {
                    "keywords": [
                        "Lasmiditan",
                        "Phase 3",
                        "studies",
                        "onset of effect",
                        "patients",
                        "Triptan"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}